August 1, 2022

AOP Health Starts Research for Leukemia Treatment

AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term. Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the […]

Read More

AOP Health commence la recherche d’un traitement pour la leucémie

AOP Health a signé un accord avec Leukos Biotech pour la poursuite du développement d’une substance chimique récemment découverte. Avec cet accord, AOP Health élargit encore davantage le domaine de la recherche sur l’hémato-oncologie et propose des options de traitement supplémentaires à certains patients atteints de leucémie sur le long terme. VIENNE, Autriche, 01 août […]

Read More

Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease  

WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it has received approval of its Investigational New Drug (IND) application from the National Medical Products […]

Read More

Drug traffickers jailed for 15 years

GAUTENG – The Kempton Park Regional Court sentenced two accused to 15 years imprisonment on 27 July 2022 for dealing in drugs.On 14 July 2019, the Germiston-based Hawks’ Serious Organised Crime Investigation team with the South African Revenue Service …

Read More

Minister Joe Phaahla: International AIDS Conference

Speaking notes by Minister of Health, Dr Joe Phaahla during a panel discission on – “how countries work towards achieving national and global prevention targets as defined in the road map” – Montreal, CanadaSouth Africa has made remarkable progr…

Read More